Moderna Archives - CFO

Merck Drops Out of COVID-19 Vaccine Race

Risk & Compliance

Merck Drops Out of COVID-19 Vaccine Race

Merck's announcement that it is shelving its two vaccine candidates "marks a shocking setback for one of the most storied vaccine makers."

By Matthew Heller | January 25, 2021

2020 CFO Departures and Arrivals

2020 CFO Departures and Arrivals

From Ford to Cisco, Macy’s to Moderna many companies saw changes at the CFO position last year.

By Lauren Muskett | January 4, 2021

Moderna Q3 Revenues Beat Estimates

Financial Performance

Moderna Q3 Revenues Beat Estimates

The biotech is preparing for the global launch of its potential COVID-19 vaccine.

By Lauren Muskett | October 29, 2020

J&J Speeds Up Timeline for Coronavirus Vaccine

Risk & Compliance

J&J Speeds Up Timeline for Coronavirus Vaccine

After lagging behind other companies, J&J now expects to begin a late-stage study of its vaccine candidate in September.

By Matthew Heller | July 16, 2020

CFOs On the Move: Week Ending June 5

CFOs On the Move: Week Ending June 5

DistributionNOW, 3M, Moderna, Nielsen, Freddie Mac, Tesco, Comcast, Tasty Restaurant Group, WOW!

By Lauren Muskett | June 5, 2020

Moderna Stock Soars on COVID Vaccine Results

Risk & Compliance

Moderna Stock Soars on COVID Vaccine Results

Interim data from a Phase 1 study showed Moderna's vaccine candidate stimulated an immune response against the virus in people.

By Matthew Heller | May 18, 2020

Moderna Gets $483M to Fund Corona Vaccine

Risk & Compliance

Moderna Gets $483M to Fund Corona Vaccine

The grant from the U.S. government will boost Moderna's efforts to develop what is “among the most advanced coronavirus vaccine candidates.”

By Matthew Heller | April 17, 2020

Biotech’s Moderna Poised for Market Debut

Biotech’s Moderna Poised for Market Debut

The startup's IPO would raise capital for "a new category of transformative medicines based on messenger RNA."

By Matthew Heller | December 6, 2018